Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression

INTRODUCTION: Ketamine treatment is capable of significant and rapid symptom improvement in adults with treatment-resistant depression (TRD). A limitation of ketamine treatment in TRD is the relatively short duration of time to relapse (e.g., median 2–4 weeks). The objective of the systematic review...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Ther
Autors principals: McMullen, Eric P., Lee, Yena, Lipsitz, Orly, Lui, Leanna M. W., Vinberg, Maj, Ho, Roger, Rodrigues, Nelson B., Rosenblat, Joshua D., Cao, Bing, Gill, Hartej, Teopiz, Kayla M., Cha, Danielle S., McIntyre, Roger S.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189962/
https://ncbi.nlm.nih.gov/pubmed/33929660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01732-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars